Biotech Company Connect Biopharma Raises US$115M in Series C

Connect Biopharma’s total capital pool nears the US$200 million mark

U.S.- and China-based clinical-stage biopharmaceutical company Connect Biopharma has completed a fundraise of US$115 million in a Series C round, the company announced in a statement yesterday.

The round was led by U.S.-based multi-stage investment manager RA Capital Management, the statement said. Principal at RA Capital Management Derek DiRocco will be joining Connect Biopharma’s Board of Directors.

Further, China-headquartered Lilly Asia Ventures, U.S. biotech investment fund Boxer Capital, and Swiss healthcare investor HBM Healthcare Investments, joined existing investor China venture capital firm Qiming Venture Partners in participating in the round, the statement added.

“Connect’s proprietary Immune Modulation Technology Platform can transform the development of novel therapies for a wide array of serious inflammatory and autoimmune diseases that have significant unmet clinical need,” DiRocco said in the statement.

The fresh capital will help the company prepare for and progress with clinical trials for its pipeline products, and transition preclinical programs into clinical development.

Specifically, the funding will be channeled towards backing Connect Biopharma’s ongoing Phase 2 trials for CBP-201 and CBP-307, expand the clinical development program for CBP-201, and produce clinical material for future Phase 3 trials of CBP-201 and CBP-307, the statement said.

Connect Biopharma focuses on the identification and development of immune modulating molecules.

“Connect is focused on innovating best-in-class therapies to address patient need globally, and our ability to attract top-tier global investors is an important validation of the potential value of our pipeline and its underlying technologies,” Co-founder and CEO at Connect Biopharma, Zheng Wei said.

“We believe that our wholly-owned and growing pipeline, technology, scientific and clinical expertise, and world-class investors position us for success in continued execution of our near-term objectives and attaining our long-term vision of improving care and outcomes for patients with inflammatory and autoimmune disease,” he added.

So far this year, the company has reported positive topline data from its Phase 1b study of CBP-201, and has also strengthened its intellectual property estate for CBP-307.

Further, it is expected to advance one of its product candidates, the CBP-174 molecule for the treatment of pruritus, into Phase 1 trials by Q4 this year.

Prior to its Series C, Connect Biopharma had last raised funding to the tune of $55 million in January 2019 through its Series B round, led by Hong Kong private equity growth capital investor Advantech Capital.

It had also raised $20 million in its Series A in 2017, led by Qiming Venture Partners. With its current round, it has raised nearly $200 million in total capital.

Header image by Chokniti Khongchum from Pexels

SHARE THIS STORY

Share on facebook
Share on twitter
Share on linkedin
Share on email

RELATED POSTS

5 More Business Podcasts You Need to Listen To

5 More Business Podcasts You Need to Listen To

Entrepreneurs have one thing in common—they always look for opportunities to learn and grow. To gain an understanding of running a viable business, you need to listen to the experiences of those who have emerged triumphant in the business world. A great way to do so is by tuning into a vast number of business and entrepreneurship podcasts scattered across the internet today.

5 Hobbies To Maximize Your Entrepreneurial Drive

5 Hobbies To Maximize Your Entrepreneurial Drive

Entrepreneurs are a special breed of person. They’re go-getters, risk-takers and dreamers. Yet, even the most driven entrepreneur needs to take a break from time to time. Spending every second of your day on your business is stressful, and you will lose your drive very soon. If you want to stay energetic and ready to take on new challenges at work, hobbies are what you need.

Making the Metaverse a Force for Good with the Metaverse Charity Foundation

Making the Metaverse a Force for Good with the Metaverse Charity Foundation

If you are a frequent reader of our website, you must have seen us mention The Sandbox, Decentraland and Axie Infinity. These are some of the most popular metaverses out there, and the one thing they all have in common is that they all have their origins in Asia. While Asia is home to all these metaverse projects, it suffers two main issues: the region has major rural-urban inequality as well as a significant wage difference between high-skilled and low-skilled occupations.

How Do Stores Get You to Spend More Money

How Do Stores Get You to Spend More Money?

Have you ever entered a grocery store to buy some milk but ended up with a bag full of items you didn’t even need? You’re not alone if you feel guilty for spending more money than you intended. It’s not our fault that we keep putting items in our shopping carts; we are manipulated to do so! To make sure you buy more, retailers will go all the way to carefully engineer every aspect of their store.

6 Lessons All Entrepreneurs Can Learn from Amazon Founder Jeff Bezos

6 Lessons All Entrepreneurs Can Learn from Amazon Founder Jeff Bezos

Whether you love or hate him, there’s no denying that Jeff Bezos is one of the most successful entrepreneurs of our generation. Bezos, the founder of Amazon, has built a business empire encompassing everything from ecommerce and cloud computing to artificial intelligence (AI). What can we learn from Bezos, one of the world’s wealthiest men with a net worth of US$151 billion? Here are six key lessons that all entrepreneurs can learn from the billionaire:

9 Signs of a Toxic Workplace

9 Signs of a Toxic Workplace

Workplace trends like “hustle culture” and “quiet quitting” are shining the light on unhealthy, toxic work environments and their effects on employees. Hustle culture is when you feel like you have to work yourself to the bone and do way more than others all the time; quiet quitting, a counteragent to hustle culture, is about doing the bare minimum at your job instead of going above and beyond for an exploitative employer.